ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Mankind Pharma announced that members of its wholly-owned subsidiary, Bharat Serums and Vaccines Limited (BSVL), approved its voluntary liquidation in an EGM.
Mankind Pharma's board approved the voluntary liquidation of its subsidiary, Bharat Serums and Vaccines Limited, to integrate its business into the parent company.
Mankind Pharma has incorporated a wholly-owned subsidiary in the Netherlands, "Mankind Pharma (Netherlands) B.V.", with an issued capital of ₹55.06 Crore.
Mankind Pharma has incorporated a wholly-owned subsidiary, 'Mankind Pharma (Netherlands) B.V.', in the Netherlands as previously disclosed.
Mankind Pharma has completed the sale of its 100% stake in Broadway Hospitality Services Private Limited for a cash consideration of ₹ 49 Crore.
Mankind Pharma will sell its subsidiary Broadway Hospitality Services to AKRK Projects for ₹49 Crore. The cash deal is expected to conclude by October 2026.
Mankind Pharma will incorporate a wholly-owned subsidiary in Netherlands with a 54 Crore investment. The entity will hold R&D assets and pursue niche therapy joint ventures.
Mankind Pharma approved divesting 100% stake in Broadway Hospitality for Rs. 49 Crore. It also plans to invest €5 Million to incorporate a new Netherlands-based subsidiary.
Mankind Pharma approved a ₹500 Crore investment in its subsidiary, Mankind Medicare, for capacity expansion. The capital will fund a new pharmaceutical manufacturing plant.
Mankind Pharma Limited's Board has approved the winding-up of its Sri Lankan wholly owned subsidiary, Mankind Pharma Lanka (Private) Limited. The entity had no active operations and became unviable due to regulatory changes. This closure is not expected to materially impact the company's consolidated financials.